• New York Genome Center Unveiled in Manhattan

    Bio-IT World | A remarkable public-private coalition of universities, medical centers, technology partners and philanthropists under the direction of Nancy Kelley has created the New York Genome Center (NYGC), which was officially unveiled in a ceremony in Manhattan this morning. NYGC is poised to have an immense impact on New York science, and will quickly become one of the largest genome centers in the U.S.

    Nov 2, 2011

  • Cornell Announces Red Cloud Computing Service

    Bio-IT World | Cornell University has announced an on-demand research computing service called Red Cloud available to researchers at Cornell and other academic institutions for a set subscription fee. 

    Nov 1, 2011

  • Japanese Genomics Organization Chooses New SGI HPC System

    Bio-IT World | The Institute for Chemical Research (ICR) at Kyoto University in Japan, has selected an SGI UV 1000 high performance computing and storage system to advance its genomics research and enable GenomeNet, a network of database and computational services for genome research and related research areas in biomedical sciences, operated by the Kyoto University Bioinformatics Center.

    Oct 31, 2011

  • Max Planck Institute Heads to South America

    Nature News | Germany's Max Planck Institute has opened a new research facility in Buenos Aires, Argentina. The branch will focus mainly on neurosciences, drug desing, cellular plasticity and stem cell research.

    Oct 31, 2011

  • Archon Genomics X Prize Revamps Rules Prior to 2013 Kick Off

    Bio-IT World |  The Archon Genomics X Prize, which offers a $10 million purse for a significant breakthrough in the whole genome sequencing of 100 genomes, has announced adjustments to its rules, criteria, and timing, as well as officially welcoming a major new sponsor – Medco Health Solutions. The new-look competition will kick off in January 2013, with entrants having 30 days to sequence the genomes of 100 centenarians for less than $1,000 apiece.

    Oct 26, 2011

  • Layoffs Looming as Illumina Restructures

    Sign On San Diego |  Amid news that Illumina plans to restructure its business because of slowing sales, setting the stage for layoffs at the leading NGS instrument maker in the wake of disappointing sales figures, the company has also revealed plans to create a new unit devoted to forging business with hospitals and physicians. “We really need to create a much stronger focus on customers that are using our technologies in clinical applications,” said CEO Jay Flatley. 

     

    Oct 26, 2011

  • Pistoia Alliance Announces NGS Data Compression Algorithm Competition

    Bio-IT World | The Pistoia Alliance of more than 50 life science companies, vendors, publishers, and academic groups, has launched a competition to find the best algorithm for compressing next-generation sequencing (NGS) data, with a $15,000 first prize. 

    Oct 25, 2011

  • Genia’s Nanopore/Microchip Technology Gains Life Technologies’ Support

    Bio-IT World EXCLUSIVE | From a chance meeting in a Silicon Valley Starbucks, Genia is the latest start-up vying to make an impact in the increasingly crowded field of nanopore sequencing, featuring a novel microchip platform that has already caught the attention of one of the giants in next-generation sequencing.

    Oct 21, 2011

  • Cycle Computing Offers $10,000 Cloud Prize in BigScience Challenge

    Bio-IT World | Building on some positive industry and media response earlier this year to its success in spinning up a 30,000-core supercomputer in the Amazon Cloud, Cycle Computing is planning to offer $10,000 prize in computing time “to help researchers answer questions that will help humanity.”

    Oct 20, 2011

  • Recent Sequencing Plans by the Numbers

    Xconomy | What do 10,000 people with autism, 50,000 people in some remote islands in the North Atlantic, and 1,000 healthy old folks in southern California have in common?

    Oct 18, 2011

  • A QuantuMDx Leap for Handheld DNA Sequencing

    Bio-IT World |  Capping off an exciting International Congress of Human Genetics in Montreal, clinical geneticist Sir John Burn provided the first glimpse at a disruptive nanowire technology for rapid DNA genotyping, produced by UK company QuantuMDx, that could eventually mature into the world’s first handheld DNA sequencer. 

     

    Oct 16, 2011

  • DNAnexus to Host Short Read Archive (SRA) Database in Google Cloud

    Bio-IT World | DNAnexus says it will offer free, improved access to the Short Read Archive (SRA), the funding-challenged trove of NGS read data hosted by the National Center for Biotechnology Information (NCBI), in a new partnership with Google Cloud Storage. 

    Oct 12, 2011

  • Illumina Launches BaseSpace Cloud Platform for MiSeq

    Bio-IT World | Illumina’s much anticipated MiSeq instrument for next-gen sequencing enters full production with a series of enhancements including streamlined sample processing and a new Cloud platform called BaseSpace to faciliate data management and collaboration.  

    Oct 12, 2011

  • Accelrys Launches Next-Generation Informatics Suite and Cloud Portal

    Bio-IT World | Accelrys is releasing its "next-generation informatics suite" this week, including a chemical registration system and a Cloud-based portal called HEOS in partnership with SCYNEXIS, in what one company executive calls the first coherent suite to span scientists' daily workflows since the 2010 merger with Symyx.  

     

    Oct 12, 2011

  • Best Practices 2012: Call for Entries

    Bio-IT World | The 2012 Bio-IT World Best Practices competition has released its call for entries. Since 2003, Bio-IT World's Best Practices competition has been recognizing outstanding examples of technology and strategic innovation initiatives across the drug discovery enterprise. The deadline for entry is January 13, 2012, and the early bird deadline is December 16, 2011.  

     

    Oct 8, 2011

  • Eric Perakslis Appointed New CIO of FDA

    Bio-IT World | Eric Perakslis, formerly Chief Information Officer (CIO) of R&D Information Technology at Johnson & Johnson Pharmaceutical R&D, has joined the U.S. Food and Drug Administration as the FDA’s new Chief Information Officer and Chief Scientist (Informatics).    

    Oct 10, 2011

  • VCs Pull Back on Biotech Investments and Its FDA's Fault

    Wall Street Journal | Venture capitalists look to be steering their money away from biotech, a development that life science investors fear will push jobs and treatment overseas. The main reason for the shift? A Food and Drug Administration the investors says is dysfunctional, unpredictable, and risk-averse.

    Oct 6, 2011

  • Powering Preventative Medicine

    Bio-IT World  | DNA Electronics certainly sounds like the quintessential bio-IT company, but this London firm is quietly making waves in the field of next-generation sequencing (NGS) and molecular diagnostics. Some of the firm’s key intellectual property (IP) is providing the foundation for present and future semiconductor sequencing platforms. And some of that same technology lies at the core of the firm’s newly developed handheld device, dubbed the SNP-DR, which can detect dozens of DNA variants in a saliva sample within 20-30 minutes.  

     

    Oct 6, 2011

  • Big Pharma's Last Refuge

    Bio-IT World | In the previous issue of Bio•IT World, my fellow columnist Ernie Bush posed the question, what are the limits to collaboration among pharmaceutical companies? This same question was faced by the telecommunications industry in 1913, albeit during an era of ascendancy and not senescence. This led to a solution that lasted 70 years. Could history repeat itself?

    Oct 4, 2011

  • Reevaluating the Role of the Research Librarian in Pharma R&D

    Bio-IT World | If your image of a research librarian is the soft-spoken, bespectacled woman politely shushing you when you’re talking in the library, that outdated perception couldn’t be further from the truth. Research librarians are highly skilled data analysts and business experts playing key roles in driving company performance, particularly in life sciences organizations. They ensure the most talented project teams make the right choices, perform at their highest levels, and reach outcomes their companies are striving for.  

     

    Oct 3, 2011